Gama testas - Company finances
|
EUR
|
2019
From: 2019-12-12
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | - | - | - | - | 61,710 | 239,694 | 356,205 |
| Profit before tax | 0 | -1,310 | -2,060 | 0 | 35,705 | 143,657 | 77,689 |
| Net profit | 0 | -1,310 | -2,060 | 0 | 34,109 | 136,474 | 65,168 |
| Equity | 2,500 | 1,190 | -870 | 0 | 33,239 | 169,712 | 234,880 |
| Liabilities | 0 | 0 | 870 | 0 | 14,730 | 17,897 | 32,470 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 168,023 | 3,966 |
| Current assets | 2,500 | 1,190 | 0 | 0 | 47,969 | 19,586 | 338,784 |
| Total assets | 2,500 | 1,190 | 0 | 0 | 47,969 | 187,609 | 342,750 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 2,307 | 9,389 | 47,018 |
| Social insurance contributions | - | - | - | - | - | 9,094 | 42,001 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | - | - | - | - | +288.4% | +48.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -110.1% | - | - | 71.1% | 72.7% | 19.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | -110.1% | - | - | 102.6% | 80.4% | 27.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 55.3% | 56.9% | 18.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 57.9% | 59.9% | 21.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.4 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | 37,975 | 57,526 | 52,128 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gama testas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-24 | 2026-08-12 | 51.62 |
| 2026-07-23 | 2026-07-23 | 2929.98 |
| 2026-07-19 | 2026-07-22 | 2878.36 |
| 2026-07-16 | 2026-07-17 | 2878.36 |
| 2026-06-26 | 2026-07-06 | 3399.74 |
| 2026-06-16 | 2026-06-25 | 4269.50 |
| 2026-05-27 | 2026-05-31 | 3583.32 |
| 2026-05-17 | 2026-05-26 | 4292.21 |
| 2026-05-12 | 2026-05-14 | 39.47 |
| 2026-05-04 | 2026-05-11 | 39.49 |
| 2026-05-03 | 2026-05-03 | 2103.56 |
| 2026-04-27 | 2026-04-29 | 2103.56 |
| 2026-04-26 | 2026-04-26 | 2064.07 |
| 2026-04-24 | 2026-04-25 | 2103.56 |
| 2026-04-20 | 2026-04-23 | 2064.07 |
| 2026-03-29 | 2026-04-06 | 3350.05 |
| 2026-03-17 | 2026-03-27 | 3350.05 |
| 2026-02-27 | 2026-03-02 | 2516.78 |
| 2026-02-18 | 2026-02-26 | 3340.28 |
| 2026-01-27 | 2026-01-28 | 2807.28 |
| 2026-01-21 | 2026-01-26 | 2994.92 |
| 2026-01-16 | 2026-01-20 | 2972.96 |
| 2025-12-16 | 2025-12-21 | 2508.87 |
| 2025-11-18 | 2025-12-01 | 4458.59 |
| 2025-07-24 | 2025-08-18 | 4.45 |
| 2025-06-17 | 2025-07-01 | 21.34 |
| 2025-05-16 | 2025-06-04 | 4.02 |
| 2025-05-04 | 2025-05-04 | 4.02 |
| 2025-04-30 | 2025-04-30 | 1801.28 |
| 2025-04-24 | 2025-04-29 | 4.02 |
| 2025-04-16 | 2025-04-23 | 1801.28 |
| 2025-03-27 | 2025-03-31 | 598.81 |
| 2025-03-18 | 2025-03-26 | 1190.42 |
| 2024-10-24 | 2024-11-03 | 3.64 |
| 2024-08-19 | 2024-08-28 | 965.61 |
| 2024-02-19 | 2024-03-14 | 0.20 |
| 2024-01-23 | 2024-02-13 | 0.20 |
| 2023-10-24 | 2023-11-02 | 1.52 |
| 2023-10-17 | 2023-10-17 | 344.63 |
| 2023-09-18 | 2023-09-21 | 342.52 |
| 2023-07-27 | 2023-07-30 | 115.96 |
| 2023-07-26 | 2023-07-26 | 203.87 |
| 2023-07-24 | 2023-07-25 | 205.26 |
| 2023-07-18 | 2023-07-23 | 203.87 |
| 2023-06-28 | 2023-06-28 | 270.17 |
| 2023-06-16 | 2023-06-27 | 337.01 |
| 2021-11-05 | 2021-11-16 | 7.23 |
| 2021-08-17 | 2021-11-04 | 2.43 |
Gama testas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-14 | 2026-08-29 | 37.06 |
| 2026-08-02 | 2026-08-10 | 3781.74 |
| 2026-07-14 | 2026-08-01 | 3900.94 |
| 2026-07-05 | 2026-07-13 | 6268.44 |
| 2026-06-30 | 2026-07-04 | 6255.0 |
| 2026-06-26 | 2026-06-29 | 6255.66 |
| 2026-06-01 | 2026-06-02 | 2058.56 |
| 2026-05-31 | 2026-05-31 | 2053.7 |
| 2026-05-25 | 2026-05-30 | 2054.96 |
| 2026-05-22 | 2026-05-24 | 2050.61 |
| 2026-05-17 | 2026-05-21 | 2279.46 |
| 2026-05-11 | 2026-05-16 | 2219.75 |
| 2026-05-06 | 2026-05-10 | 30.9 |
| 2026-05-01 | 2026-05-05 | 2450.91 |
| 2026-04-30 | 2026-04-30 | 2431.26 |
| 2026-04-26 | 2026-04-29 | 2420.01 |
| 2026-04-24 | 2026-04-25 | 2518.13 |
| 2026-04-17 | 2026-04-23 | 2908.07 |
| 2026-04-08 | 2026-04-16 | 8.76 |
| 2026-04-01 | 2026-04-07 | 5232.26 |
| 2026-03-27 | 2026-03-31 | 5223.5 |
| 2026-03-22 | 2026-03-26 | 5297.4 |
| 2026-03-13 | 2026-03-17 | 2828.87 |
| 2026-03-08 | 2026-03-08 | 18.65 |
| 2026-03-02 | 2026-03-07 | 1411.89 |
| 2026-02-27 | 2026-03-01 | 1393.24 |
| 2026-02-21 | 2026-02-26 | 1708.24 |
| 2026-02-16 | 2026-02-20 | 1533.24 |
| 2026-01-29 | 2026-01-29 | 591.0 |
| 2026-01-27 | 2026-01-28 | 6.7 |
| 2026-01-22 | 2026-01-26 | 6.16 |
| 2026-01-15 | 2026-01-21 | 2079.95 |
| 2025-09-28 | 2025-10-18 | 1.23 |
| 2025-09-13 | 2025-09-23 | 1.23 |
| 2025-09-12 | 2025-09-12 | 41.05 |
| 2025-09-11 | 2025-09-11 | 45.52 |
| 2025-09-02 | 2025-09-10 | 4.98 |
| 2025-09-01 | 2025-09-01 | 3205.1 |
| 2025-08-28 | 2025-08-31 | 3200.95 |
| 2025-07-24 | 2025-07-31 | 56.77 |
| 2025-07-18 | 2025-07-22 | 7156.89 |
| 2025-07-16 | 2025-07-20 | 1568.63 |
| 2025-07-11 | 2025-07-15 | 1556.46 |
| 2025-06-14 | 2025-06-19 | 50.29 |
| 2025-04-11 | 2025-04-23 | 424.17 |
| 2025-04-02 | 2025-04-10 | 1.92 |
| 2025-03-31 | 2025-04-01 | 154.02 |
| 2025-03-22 | 2025-03-30 | 154.11 |
| 2025-03-12 | 2025-03-21 | 227.11 |
| 2025-01-15 | 2025-01-15 | 1180.93 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Gama testas, UAB (code 305390685) is a Private Limited Liability Company engaged in testing and analysis of materials. In 2025, the company generated revenue of €356.2K, up 48.6% year on year, and reported net profit of €65.2K. The net profit margin was 18.3%, lower than in 2023 and 2024, but profitability remained positive. Over the three-year period, revenue increased from €61.7K in 2023 to €239.7K in 2024 and then to €356.2K in 2025, showing strong expansion. Net profit rose from €34.1K in 2023 to €136.5K in 2024 before easing in 2025, though it stayed above the 2023 level. At year-end 2025, total assets stood at €342.8K, equity at €234.9K, and liabilities at €32.5K, indicating a solid balance sheet position. Key ratios for 2025 were ROE of 27.8%, ROA of 19.0%, debt-to-equity of 0.14, and asset turnover of 1.04x. Revenue per employee was €59.4K and profit per employee was €10.9K.